The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

RELPAX 40 mg film-coated tablets

40 milligram(s) Film-coated tablet

Lexon (UK) LtdPPA1097/020/001

Main Information

Trade NameRELPAX 40 mg film-coated tablets
Active SubstancesELETRIPTAN
Strength40 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderLexon (UK) Ltd
Licence NumberPPA1097/020/001

Group Information

ATC CodeN02CC Selective serotonin (5HT1) agonists
N02CC06 eletriptan


Licence Issued28/07/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back